Hypertension

When high blood pressure was induced in young mice, they had bone loss and osteoporosis-related bone damage comparable to older mice, according to new research presented at the American Heart Association’s Hypertension Scientific Sessions 2022 conference. Read More

Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes. Read More

Researchers at Vanderbilt University Medical Center have discovered a new genetic disease that causes a severe form of neurogenic orthostatic hypotension, a rapid drop in blood pressure upon standing that can cause fainting. Read More

Heat therapy could offer a novel nonpharmacologic approach for treating the overnight hypertension that affects patients with autonomic failure. Read More

Insight into the pathophysiology of an enigmatic and debilitating disease suggests new treatment approaches. Read More

Oxidative stress and toxic products called isolevuglandins in mitochondria play a role in endothelial dysfunction and hypertension — and getting rid of them with a special “scavenger” molecule has therapeutic potential. Read More

Excess dietary salt activates immune cells to induce inflammation and hypertension, supporting current recommendations for low sodium consumption. Read More

Black men with high blood pressure could benefit from a research study beginning this month to check their vitals while they are getting a haircut at a barbershop. Read More

Vanderbilt researchers have discovered that a protein called SGK1 in immune cells is activated by sodium, leading to the development of salt-sensitive hypertension. Read More

Reading a comic book may improve the health of hypertension patients, or at least that’s the goal of a new study at Vanderbilt University Medical Center. Read More

A six-member group of biomedical scientists from Europe and the United States, including Eric Delpire, PhD, MS, professor of Anesthesiology, has been awarded a $6 million grant to study the role of dietary potassium in hypertension. Read More

Vanderbilt researchers have identified a pathway that links excess sodium, inflammation and hypertension. Read More

Vanderbilt’s David Robertson, M.D., and Meena Madhur, M.D., Ph.D., were recognized by the American Heart Association’s Council on Hypertension during the annual Council on Hypertension Scientific Sessions meeting in Orlando this week. Read More

Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease. Read More

The number and percentage of patients treated at emergency departments for hypertension are on the rise across the United States, according to a Vanderbilt study published recently in The American Journal of Cardiology. Read More

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older. Read More

Despite prior epidemiologic and experimental data to the contrary, new research shows that vitamin D supplementation does not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency. Read More

The evidence is increasing: the immune system and inflammation are key contributors to high blood pressure. Read More

New findings suggest that misfolded proteins accumulate in the heart atria, particularly in patients with hypertension, and may contribute to atrial heart disease. Read More

A copy repairman who couldn’t do his job anymore and was forced to take medical leave has returned to work. A woman who couldn’t walk from her car to her desk job has enough energy to redecorate her house. A 42-year-old mother who was too sick to care for her… Read More